JDRF to Provide Additional Support for Upcoming Clinical Trial of ViaCyte's Encapsulated Cell Therapy for Type 1 Diabetes
JDRF, the world’s largest non-profit supporter of type 1 diabetes (T1D) research, and ViaCyte, Inc., a leading regenerative medicine company, jointly announced that JDRF is providing additional milestone-based funding for the continued development of ViaCyte’s VC-01™ ...
Six-Time Ironman and Type 1 Diabetes Athlete Sebastien Sasseville to Take on Solo 7500 km Run Across Canada
Endurance athlete, six-time Ironman and one of more than 3 million Canadians living with diabetes, Sebastien Sasseville will undertake a solo run across the country in a personal mission to inspire, educate and empower other people with diabetes to pursue their dreams.
Research program will investigate an exciting new hypothesis about lost beta cell function in type 1 diabetes that may change our basic understanding of the disease and lead to novel prevention and restoration therapies
TORONTO (December 23, 2013) – Patrick Brown, Member of Parliament for Barrie and Chair of the All-Party Juvenile Diabetes Caucus on Parliament Hill, is a devoted advocate of type 1 diabetes (T1D) and longstanding supporter of JDRF. An Appreciation Luncheon was held in Barrie on December 17, 2013 ...
New York, NY, December 4, 2013 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today the recipients of the 2013 JDRF awards for outstanding contributions to T1D research. The awards were announced at a meeting of the JDRF Board of Directors.
JDRF showcases advancements in T1D pregnancy care; highlighting JDRF CCTN and the CONCEPTT Trial, and exploring the challenges of managing T1D through pregnancy with JDRF supporter Vanessa Oliver.
When 11-year-old Noah Steinley found out that he would get to be on the sideline for the 101st Grey Cup, he was very surprised.
JDRF in the Globe and Mail, November 12, 2013: Beyond searching for cure, JDRF aims to improve the lives of people with T1D.
JDRF showcases the Outreach Program including tools and resources available; highlights Eli Lilly’s exciting new program; and discusses how to get involved through November and beyond.
Canadians Living With Type 1 Diabetes for 50 Years Can Have a Significant Impact in Discovering Factors for Success in T1D Research
JDRF is excited to support a nationwide research study exploring longevity in type 1 diabetes (T1D). Toronto-based researchers at Mount Sinai Hospital are creating a national registry of Canadians who have been living with T1D for 50 years or more, and invite them to participate in a mail-based national ...
JDRF in the Globe and Mail, November 7, 2013: Advances in type 1 diabetes (T1D) treatments making difference for family facing a double challenge.
JDRF profiles a family living with T1D; discusses diabetes in Canada; and how JDRF-funded research is making a difference.